Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users.
Parrott
A C
AC
Buchanan
T
T
Heffernan
T M
TM
Scholey
A
A
Ling
J
J
Rodgers
J
J
D001921:Brain / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D006213:Hallucinogens / Q000009:adverse effects*; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects*; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects*; D010302:Parkinson Disease, Secondary / Q000209:etiology* / Q000378:metabolism; D011596:Psychomotor Disorders / Q000139:chemically induced*
D006213:Hallucinogens; D013287:Illicit Drugs; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D004298:Dopamine